Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06274034

MUSE-S Headband System for Improving Anxiety and Insomnia Among Breast Cancer Survivors

Pilot Study of a Wearable EEG Headband as a Meditation Device for Breast Cancer Survivors

Status
Recruiting
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Mayo Clinic · Academic / Other
Sex
Female
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This early phase I trial evaluates the feasibility and impact of a meditation headband system (MUSE-S) for breast cancer survivors. Anxiety and insomnia are among the most common distresses in breast cancer survivors during and after chemotherapy, in part due to the side effects of chemotherapy, fear of cancer coming back, progression of the cancer, and uncertainty of the future. These distresses impair patients' well-being and quality of life (QOL) in general, and their cancer treatment adherence and effectiveness in particular. Meditation has been demonstrated to be an effective management tool of stress and anxiety and is given the highest level of evidence (grade A) in the systematic review-based guidelines by the Society of Integrative Medicine. The portable, interactive, electroencephalographic (EEG) Muse headband guided meditation has been shown to improve fatigue, QOL, and stress in newly diagnosed breast cancer patients. The MUSE-S Headband System may decrease anxiety and insomnia among breast cancer survivors.

Detailed description

PRIMARY OBJECTIVES: I. To evaluate the frequency of use of meditation (a stress management technique) among breast cancer survivors. II. To evaluate the feasibility of a wearable EEG headband, MUSE S, together with smartphone or tablet application (app) to guide breast cancer survivors' interactive meditation and sleep support. III. To measure the impact of interactive meditation and sleep support through MUSE S among breast cancer survivors during or after chemotherapy on improving symptoms of anxiety and insomnia. OUTLINE: Patients wear the MUSE S headband to bed every night for 8 weeks and meditate using the MUSE phone app during day hours for at least 5 minutes over 8 weeks.

Conditions

Interventions

TypeNameDescription
OTHERElectronic Health Record ReviewAncillary studies
OTHERMedical Device Usage and EvaluationWear MUSE S headband
PROCEDUREMeditation TherapyParticipate in meditation
OTHERSurvey AdministrationAncillary studies

Timeline

Start date
2024-01-08
Primary completion
2029-01-31
Completion
2029-01-31
First posted
2024-02-23
Last updated
2025-12-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06274034. Inclusion in this directory is not an endorsement.